ICMR-MINDS Wins Gold at National Awards for e-Governance 2026

IMT News Desk
IMT News Desk
· 2 min read
ICMR’s MINDS digital mental health platform wins Gold at the National Awards for e-Governance 2026 for AI-driven, citizen-centric services.

The Indian Council of Medical Research’s flagship initiative, ICMR-MINDS, has been conferred the Gold Award at the National Awards for e-Governance 2026, recognising its innovative use of digital technology to strengthen public health services.

The project received the honour under Category 2, “Innovation by Use of AI and Other New Age Technologies for Providing Citizen-Centric Services,” during the 29th National Conference on e-Governance held in Jaipur on July 1-2, 2026. The award was presented by Union Minister of State for Personnel, Public Grievances and Pensions, Dr Jitendra Singh, in the presence of senior central and state government officials.

ICMR-MINDS is a National Health Research Priority project focused on integrating the screening and management of mental and substance use disorders with other non-communicable diseases in routine health services. At the core of the initiative is a Clinical Decision Support System that enables task-shifting of standardised mental health screening, assessment, follow-up and routine management from specialists to trained non-specialist frontline healthcare providers, backed by evidence-based digital decision support. This approach is designed to make mental health care more accessible and consistent, particularly in resource-constrained settings, while maintaining quality and safety.

Speaking on the recognition, Director General of ICMR, Dr Rajiv Bahl, said that ICMR will continue to pioneer data-driven, scalable technology interventions to address complex public health challenges. He noted that the MINDS platform demonstrates how artificial intelligence and digital tools can be harnessed to support frontline health workers and improve care for conditions that often go underdiagnosed and undertreated. The Ministry of Health and Family Welfare has highlighted the project as a model for integrating mental health into broader non-communicable disease programmes, underscoring its potential to inform national and state-level strategies in the years ahead.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk